Age greater than or equal to 18 years
Have RA, as defined by the 1987 revised American College of Rheumatology criteria
In sustained clinical remission for the last 6 months while receiving treatment with either etanercept, infliximab, or adalimumab, and greater than or equal to 1 DMARD (methotrexate, hydroxychloroquine, sulfasalazine, leflunomide, minocycline, cyclosporine, azathioprine, gold, penicillamine). DAS28 should be less than 2.6 on each visit over the preceding 6 months, with at least one visit 2-4 months before enrollment. If there is no visit 6 months before enrollment, the nearest visit in the 6-12 month period before enrollment should be considered and have a DAS28 less than 2.6.

NCT01793519_inc_T1
Person
Age
NCT01793519_inc_T2
Value
greater than or equal to 18 years
NCT01793519_inc_T3
Condition
RA
NCT01793519_inc_T4
Qualifier
1987 revised American College of Rheumatology criteria
NCT01793519_inc_T5
Condition
sustained clinical remission
NCT01793519_inc_T6
Multiplier
for the last 6 months
NCT01793519_inc_T7
Drug
etanercept
NCT01793519_inc_T8
Drug
infliximab
NCT01793519_inc_T9
Drug
adalimumab
NCT01793519_inc_T10
Multiplier
greater than or equal to 1
NCT01793519_inc_T11
Drug
DMARD
NCT01793519_inc_T12
Drug
methotrexate
NCT01793519_inc_T13
Drug
hydroxychloroquine
NCT01793519_inc_T14
Drug
sulfasalazine
NCT01793519_inc_T15
Drug
leflunomide
NCT01793519_inc_T16
Drug
minocycline
NCT01793519_inc_T17
Drug
cyclosporine
NCT01793519_inc_T18
Drug
azathioprine
NCT01793519_inc_T19
Drug
gold
NCT01793519_inc_T20
Drug
penicillamine
NCT01793519_inc_T21
Scope
methotrexate, hydroxychloroquine, sulfasalazine, leflunomide, minocycline, cyclosporine, azathioprine, gold, penicillamine
NCT01793519_inc_T22
Measurement
DAS28
NCT01793519_inc_T23
Value
less than 2.6
NCT01793519_inc_T24
Multiplier
over the preceding 6 months
NCT01793519_inc_T25
Multiplier
at least one
NCT01793519_inc_T26
Procedure
visit
NCT01793519_inc_T27
Procedure
visit
NCT01793519_inc_T28
Multiplier
on each visit
NCT01793519_inc_T29
Temporal
2-4 months before enrollment